Chemotherapy

Results: 2361



#Item
1

PDF Document

Add to Reading List

Source URL: www.chemotherapy.com

- Date: 2017-01-24 22:08:21
    2

    PDF Document

    Add to Reading List

    Source URL: www.chemotherapy.com

    - Date: 2017-01-24 22:08:21
      3#4503 A Small Molecule Glycomimetic Antagonist of E-selectin (GMIPrevents Pancreatic Tumor Metastasis and Offers Improved Efficacy of Chemotherapy Maria M. Steele1, BS, Prakash Radhakrishnan1, PhD, John L. Magnani

      #4503 A Small Molecule Glycomimetic Antagonist of E-selectin (GMIPrevents Pancreatic Tumor Metastasis and Offers Improved Efficacy of Chemotherapy Maria M. Steele1, BS, Prakash Radhakrishnan1, PhD, John L. Magnani

      Add to Reading List

      Source URL: glycomimetics.com

      Language: English - Date: 2014-04-10 23:45:38
        4chemotherapy.com  www.chemotherapy.com GETTING STARTED Getting Started Questions Worksheet

        chemotherapy.com www.chemotherapy.com GETTING STARTED Getting Started Questions Worksheet

        Add to Reading List

        Source URL: www.chemotherapy.com

        Language: English - Date: 2017-01-24 22:08:21
          5TEARS FOR AN UNKNOWN SOLDIER As I watch my mother try to come to terms with the news that she has cancer for the third time and the look of trepidation on her face when she hears that chemotherapy will be required one mo

          TEARS FOR AN UNKNOWN SOLDIER As I watch my mother try to come to terms with the news that she has cancer for the third time and the look of trepidation on her face when she hears that chemotherapy will be required one mo

          Add to Reading List

          Source URL: www.peacekeepers.asn.au

          Language: English - Date: 2010-03-30 20:21:07
            6ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2001, p. 1894–/$04.00⫹0 DOI: AAC–Copyright © 2001, American Society for Microbiology. All Rights Reserved. Vol. 45, No. 6

            ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, June 2001, p. 1894–/$04.00⫹0 DOI: AAC–Copyright © 2001, American Society for Microbiology. All Rights Reserved. Vol. 45, No. 6

            Add to Reading List

            Source URL: entomology.tfrec.wsu.edu

            Language: English - Date: 2005-06-09 13:15:32
              7GMI-1271, a Novel E-Selectin Antagonist, Combined with Induction Chemotherapy in Elderly Patients with Untreated AML Daniel J. DeAngelo*1, Brian A. Jonas2, Dale L. Bixby3, Pamela S. Becker4, Michael E. O’Dwyer5, Anjali

              GMI-1271, a Novel E-Selectin Antagonist, Combined with Induction Chemotherapy in Elderly Patients with Untreated AML Daniel J. DeAngelo*1, Brian A. Jonas2, Dale L. Bixby3, Pamela S. Becker4, Michael E. O’Dwyer5, Anjali

              Add to Reading List

              Source URL: glycomimetics.com

              Language: English - Date: 2017-06-01 12:20:20
                8ADMINISTRATION OF THE DUAL E-SELECTIN/CXCR4 ANTAGONIST, GMI-1359, RESULTS IN A UNIQUE PROFILE OF TUMOR MOBILIZATION FROM THE BONE MARROW AND FACILITATION OF CHEMOTHERAPY IN A MURINE MODEL OF FLT3 ITD AML Abstract #  2826

                ADMINISTRATION OF THE DUAL E-SELECTIN/CXCR4 ANTAGONIST, GMI-1359, RESULTS IN A UNIQUE PROFILE OF TUMOR MOBILIZATION FROM THE BONE MARROW AND FACILITATION OF CHEMOTHERAPY IN A MURINE MODEL OF FLT3 ITD AML Abstract # 2826

                Add to Reading List

                Source URL: glycomimetics.com

                Language: English - Date: 2016-12-12 15:21:24
                  9Abstract #  The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features  4317

                  Abstract # The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features 4317

                  Add to Reading List

                  Source URL: www.xentech.eu

                  Language: English - Date: 2015-12-22 11:05:09
                    10A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

                    A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan

                    Add to Reading List

                    Source URL: glycomimetics.com

                    Language: English - Date: 2016-12-05 13:18:26